Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JKB-122 in Refractory/Intolerant Autoimmune Hepatitis
NCT02556372Phase 2Completed
- Sponsor
- TaiwanJ Pharmaceuticals Co., Ltd.
- Start
- Apr 2016
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in autoimmune hepatitis (AIH), sponsored by TaiwanJ Pharmaceuticals Co., Ltd.. Started Apr 2016; status: completed.
02
Drugs
naltrexone
03
Conditions
autoimmune hepatitis (AIH)
Beyond the preview
Go deeper on NCT02556372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02556372.